Warning: There are an increasing number of fraudulent websites that impersonate the ECCMID. We would like to alert all our members and delegates to be aware of possible scams and to strongly advise you to only use the official ECCMID online registration and accommodation services for your bookings.

Pipeline Corner

Join us for our antimicrobial drug pipeline talks at ECCMID 2017 in Vienna!

ECCMID will provide small innovative companies with a platform to give an overview of their R&D pipelines and present recent advances in their early-stage programmes to a wider audience.

ECCMID 2017 Pipeline Corner

Sunday, 23 April 2017

12:30 – 14:00, Foyer E


12:30 – 13:20 Pipeline talks

13:20 – 13:30 Experience report 

13:30 – 14:00 Discussion, networking

ePosters are accessible via the congress app and on dedicated terminals until the end of the congress on 25 April.

Presenting companies

•    AiCuris GmbH, Germany (ePoster only)
•    Allecra Therapeutics GmbH, Germany
•    Arsanis Biosciences, Austria/United States
•    Cantab Anti-infectives Ltd, United Kingdom
•    Centauri Therapeutics Ltd, United Kingdom (ePoster only)
•    Naicons Srl., Italy
•    NovaBiotics Ltd, United Kingdom
•    Phico Therapeutics Ltd, United Kingdom
•    Scynexis Inc., United States (ePoster only)
•    Septeos, France (ePoster only)
•    Synthetic Biologics Inc., United States
•    TAXIS Pharmaceuticals Inc., United States

Experience report of Redx Pharma, United Kingdom, with Carb-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), a private-public initiative that invests in companies and research teams with antimicrobial products in development.


For more information you may contact

Dr Ursula Theuretzbacher
Center for Anti-Infective Agents
Eckpergasse 13
1180 Vienna
Phone: + 43-1-479 70 24